Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > Quantum Dot Targets Midrange Gene-Expression Studies

May 23rd, 2004

Quantum Dot Targets Midrange Gene-Expression Studies

Abstract:
When it comes to gene-expression analysis, researchers seem always to be sacrificing something. With real-time quantitative PCR, it's gene number: Though inexpensive enough to apply to large numbers of samples, each assay can test, at best, three or four transcripts simultaneously. Microarrays, on the other hand, sacrifice sample throughput, probing tens of thousands of genes in a single sample. Quantum Dot (www.qdots.com) has developed a compromise solution.

Source:
* The Scientist

Bookmark:

Related News Press

Nanomedicine

Nanoliposomes Help Efforts to Cure Bacterial Infections January 27th, 2015

Stomach acid-powered micromotors get their first test in a living animal January 27th, 2015

Engineering self-assembling amyloid fibers January 26th, 2015

Promising use of nanodiamonds in delivering cancer drug to kill cancer stem cells: NUS study shows that delivery of Epirubicin by nanodiamonds resulted in a normally lethal dosage of Epirubicin becoming a safe and effective dosage for treatment of liver cancer January 26th, 2015